The role of miR-29 family in disease

被引:84
|
作者
Horita, Masahiro [1 ]
Farquharson, Colin [1 ]
Stephen, Louise A. [1 ]
机构
[1] Univ Edinburgh, Sch Vet Studies, Roslin Inst & Royal Dick, Edinburgh EH25 9RG, Midlothian, Scotland
基金
英国生物技术与生命科学研究理事会;
关键词
cardiorenal disease; immune disease; microRNA; miRNA‐ 29; osteoarthritis; osteoporosis;
D O I
10.1002/jcb.29896
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs are small noncoding RNAs that can bind to the target sites in the 3'-untranslated region of messenger RNA to regulate posttranscriptional gene expression. Increasing evidence has identified the miR-29 family, consisting of miR-29a, miR-29b-1, miR-29b-2, and miR-29c, as key regulators of a number of biological processes. Moreover, their abnormal expression contributes to the etiology of numerous diseases. In the current review, we aimed to summarize the differential expression patterns and functional roles of the miR-29 family in the etiology of diseases including osteoarthritis, osteoporosis, cardiorenal, and immune disease. Furthermore, we highlight the therapeutic potential of targeting members of miR-29 family in these diseases. We present miR-29s as promoters of osteoblast differentiation and apoptosis but suppressors of chondrogenic and osteoclast differentiation, fibrosis, and T cell differentiation, with clear avenues for therapeutic manipulation. Further research will be crucial to identify the precise mechanism of miR-29 family in these diseases and their full potential in therapeutics.
引用
收藏
页码:696 / 715
页数:20
相关论文
共 50 条
  • [1] The role of miR-29 family members in malignant hematopoiesis
    Kollinerova, Sona
    Vassanelli, Stefano
    Modriansky, Martin
    BIOMEDICAL PAPERS-OLOMOUC, 2014, 158 (04): : 489 - 501
  • [2] The miR-29 family in osteoarthritis
    Le, L. T. T.
    Crowe, N.
    Swingler, T.
    Driscoll, C.
    Vincent, T. L.
    Barter, M. J.
    Young, D. A.
    Clark, I. M.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2015, 96 (02) : A16 - A17
  • [3] The miR-29 family in hematological malignancies
    Fiserova, Barbora
    Kubiczkova, Lenka
    Sedlarikova, Lenka
    Hajek, Roman
    Sevcikova, Sabina
    BIOMEDICAL PAPERS-OLOMOUC, 2015, 159 (02): : 184 - 191
  • [4] miR-29 family: A potential therapeutic target for cardiovascular disease
    Liu, Meng-Nan
    Luo, Gang
    Gao, Wan-Jiao
    Yang, Si-Jin
    Zhou, Hua
    PHARMACOLOGICAL RESEARCH, 2021, 166
  • [5] The role of miR-29 in pulmonary fibrosis
    Cushing, Leah
    Kuang, Pingping
    Lu, Jining
    BIOCHEMISTRY AND CELL BIOLOGY, 2015, 93 (02) : 109 - 118
  • [6] The Role of MiR-29 in the Mechanism of Fibrosis
    Wang, Min
    Huo, Zhiying
    He, Xiaoyan
    Liu, Fuyou
    Liang, Jingtao
    Wu, Lijuan
    Yang, Dongdong
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2023, 23 (19) : 1846 - 1858
  • [7] The Role of miR-29 Family in TGF-β Driven Fibrosis in Glaucomatous Optic Neuropathy
    Smyth, Aoife
    Callaghan, Breedge
    Willoughby, Colin E.
    O'Brien, Colm
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
  • [8] Overview of the miR-29 family members' function in breast cancer
    Amirian, Masoumeh
    Jafari-Nozad, Amir Masoud
    Darroudi, Majid
    Farkhondeh, Tahereh
    Samarghandian, Saeed
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 230
  • [9] The two faces of miR-29
    Slusarz, Anna
    Pulakat, Lakshmi
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2015, 16 (07) : 480 - 490
  • [10] circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family
    L Chen
    S Zhang
    J Wu
    J Cui
    L Zhong
    L Zeng
    S Ge
    Oncogene, 2017, 36 : 4551 - 4561